Connect
← Return to Chronic Lymphocytic Leukemia: Study of green tea extract inconclusive
Discussion
Chronic Lymphocytic Leukemia: Study of green tea extract inconclusive
Blood Cancers & Disorders | Last Active: Aug 12 12:58pm | Replies (63)Comment receiving replies
Patients received 2000mg EGCG twice daily for 6 months.
Following a case series publication by Dr. Shanafelt, the National Cancer Institute sponsored clinical trials through the Mayo Clinic, evaluating EGCG in 42 patients with asymptomatic CLL. Patients received 2000mg EGCG twice daily for 6 months. Results showed 69% of patients had a biological response with greater than 20% reduction in absolute leukocyte count (ALC) and/or greater than 30% in reduction in size of the lymph node area utilizing standard assessment criteria (Shanafelt T. et al. 2013).
Replies to "Patients received 2000mg EGCG twice daily for 6 months. Following a case series publication by Dr...."
Connect
Welcome @graildon. I noticed that you wished to post a URL to an article with your post. You will be able to add URLs to your posts in a few days. There is a brief period where new members can't post links. We do this to deter spammers and keep the community safe. Clearly the link you wanted to post is not spam. Please allow me to post it for you.
- Effects of Green Tea on Various Types of Indolent Low Grade B-Cell Lymphomas https://www.sciencedirect.com/science/article/pii/S0006497118729753
It’s important to note the doses cited in the article. High doses of green tea extract (EGCG) of 2000-4000mg showed to also have serious side effects and dangerous liver toxicity as members who were part of the original study have shared here.
The article above seems to suggest that low doses may also show positive results. In short, high doses are not recommended. It is advised to discuss with your oncologist.